loader

World Tenders & Procurement Opportunities

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin beta (ATC-Code: G03GA06) im Rahmen eines sogenannten Open-House-Modells

World Biggest Tenders Source

This tender with title Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin beta (ATC-Code: G03GA06) im Rahmen eines sogenannten Open-House-Modells has been published on Bidding Source portal dated 13 Aug 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Abschluss nicht exklusiver Rabattverträge nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Follitropin beta (ATC-Code: G03GA06) im Rahmen eines sogenannten Open-House-Modells
Contract notice
2019/S 155-382009
Germany
Germany-Eisenberg
13 Aug 2019
31 Jul 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – Open house drug discount agreements Dimethyl fumarate, ATC L04AX07 - 222329-2024 Germany Pharmaceutical products – Open house drug discount agreements Valproic acid, in non-sustained-release dosage form, ATC N03AG01 - 222969-2024 Germany Pharmaceutical products - Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient tobramycin (J01GB01) as part of a so-called open house model. - 222247-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1b) - 217938-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient sultamicillin (ATC code according to WHO: J01CR04) - 212806-2024 Germany Pharmaceutical products – 31. Generikaausschreibung (1a) - 216318-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient octreotide (ATC code according to WHO: H01CB02) - 214791-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V by means of an open house model for the active ingredient interferon beta-1b (ATC code according to WHO: L03AB08) - 213676-2024 Germany Pharmaceutical products – conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient fampridine (ATC code according to WHO: N07XX07) - 214649-2024 Germany Pharmaceutical products – pharmaceutical tender - 210889-2024 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans